These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11132546)

  • 41. Isolated lung perfusion with cisplatin in a rat lung solitary tumor nodule model.
    Li TS; Sugi K; Ueda K; Nawata K; Nawata S; Esato K
    Anticancer Res; 1998; 18(6A):4171-6. PubMed ID: 9891463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CPI-0004Na, a new doxorubicin prodrug, reduces growth of 3LL-H61 carcinoma lung metastases in C57BI/6 mice.
    Dasnois L; Lebtahi K; Abarca-Quinones J; Havaux N; Dupont S; Dubois V; Trouet A
    J Exp Ther Oncol; 2004 Jul; 4(2):167-9. PubMed ID: 15500012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
    Roy P; Waxman DJ
    Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor necrosis factor-alpha alters phospholipid content in the bronchoalveolar lavage-accessible space of isolated perfused rat lungs.
    Hertzog JH; Godinez MH; Godinez RI
    Crit Care Med; 1994 Dec; 22(12):1969-75. PubMed ID: 7988135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous high-performance liquid chromatographic determination of a glucuronyl prodrug of doxorubicin, doxorubicin and its metabolites in human lung tissue.
    Mürdter TE; Sperker B; Bosslet K; Fritz P; Kroemer HK
    J Chromatogr B Biomed Sci Appl; 1998 May; 709(2):289-95. PubMed ID: 9657226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doxorubicin activity is enhanced by hyperthermia in a model of ex vivo vascular perfusion of human colon carcinoma.
    Pilati P; Mocellin S; Rossi CR; Scalerta R; Alaggio R; Giacomelli L; Geroni C; Nitti D; Lise M
    World J Surg; 2003 Jun; 27(6):640-6. PubMed ID: 12734680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of adriamycin by the pH-dependent formaldehyde-releasing prodrug hexamethylenetetramine.
    Swift LP; Cutts SM; Rephaeli A; Nudelman A; Phillips DR
    Mol Cancer Ther; 2003 Feb; 2(2):189-98. PubMed ID: 12589036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secondary screening system for preclinical testing of human lung cancer therapies.
    Mulvin DW; Howard RB; Mitchell DH; Noker PE; Kruse CA; Chu HD; Bunn PA; Johnston MR
    J Natl Cancer Inst; 1992 Jan; 84(1):31-7. PubMed ID: 1310746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The isolated perfused Bovine Udder Skin.
    Pittermann W; Kietzmann M; Jackwerth B
    ALTEX; 1995; 12(4):196-200. PubMed ID: 11178435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and toxicity of isolated perfusion of lung with doxorubicin.
    Baciewicz FA; Arredondo M; Chaudhuri B; Crist KA; Basilius D; Bandyopadhyah S; Thomford NR; Chaudhuri PK
    J Surg Res; 1991 Feb; 50(2):124-8. PubMed ID: 1990216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative intracellular uptake of adriamycin and 4'-deoxydoxorubicin by non-small cell lung tumor cells in culture and its relationship to cell survival.
    Kerr DJ; Kerr AM; Freshney RI; Kaye SB
    Biochem Pharmacol; 1986 Aug; 35(16):2817-23. PubMed ID: 3741470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mathematical model for adriamycin (doxorubicin) pharmacokinetics.
    Reich SD; Steinberg F; Bachur NR; Riggs CE; Goebel R; Berman M
    Cancer Chemother Pharmacol; 1979; 3(2):125-31. PubMed ID: 509697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolated perfused rabbit lung as a model for intravascular and intrabronchial administration of bronchodilator drugs II:Isoproterenol prodrugs.
    Brazzell RK; Kostenbauder HB
    J Pharm Sci; 1982 Nov; 71(11):1274-81. PubMed ID: 7175722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolated lung perfusion with Adriamycin. A preclinical study.
    Johnston MR; Minchin R; Shull JH; Thenot JP; McManus BM; Terrill R; Boyd MR
    Cancer; 1983 Aug; 52(3):404-9. PubMed ID: 6861081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conditional oncogenicity of perfused adriamycin in the tourniquet-isolated rat limb.
    Van't Hoff SC; van Dijk WJ; Buys WJ; Van der Valk MA; Benckhuijsen C
    Carcinogenesis; 1986 Oct; 7(10):1787-9. PubMed ID: 3757178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis and pharmacokinetics of a new prodrug N-l-leucyldoxorubicin and its metabolites in plasma using HPLC with fluorescence detection.
    de Jong J; Vermorken JB; van der Vijgh WJ
    J Pharm Biomed Anal; 1992 Apr; 10(4):309-14. PubMed ID: 1420461
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug targeting and metabolic investigations of cryoprepared tumor cells with analytical electron energy loss spectroscopy.
    Wolf B; Dinger V; Weiler C; Schwinde A; Scheipers P; Kraus M
    Tumour Biol; 1996; 17(4):234-50. PubMed ID: 8685604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical correlates of in vitro effect of adriamycin on advanced lung carcinoma.
    Mattern J; Kaufmann M; Wayss K; Volm M
    Klin Wochenschr; 1976 Jul; 54(14):665-70. PubMed ID: 979067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolated Human Perfused Lung Models to Study Ex Vivo Lung Optimization.
    Ariyaratnam P; Bennett RT; Loubani M; Morice A
    Transplantation; 2016 Aug; 100(8):e41-2. PubMed ID: 27362310
    [No Abstract]   [Full Text] [Related]  

  • 60. Short-term ex vivo tissue culture models help study human lung infectionsA review.
    Xia JY; Zeng YF; Wu XJ; Xu F
    Medicine (Baltimore); 2023 Jan; 102(1):e32589. PubMed ID: 36607848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.